CervoMed

CRVONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$38.820 M

$2.87 +3.99%

Close of 7 Aug 2026

Revenue

$4.01M

#3341 by revenue

Earnings

-$27.0M

Loss-making

Shares outstanding

15,119,096

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#361Nasus PharmaNSRX$40.5M
#362Radiopharm TheranosticsRADX$40.3M
#363CervoMedCRVO$38.8M
#364Incannex HealthcareIXHL$37.7M
#365VeruVERU$37.4M

Where these numbers come from

Share counts and financials for CervoMed are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.